COVID-19 Vaccine Challenges in Developing and Developed Countries

The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlagadda, Harshani, Patel, Meet A, Gupta, Vasu, Bansal, Toram, Upadhyay, Shubekshya, Shaheen, Nour, Jain, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085716/
https://www.ncbi.nlm.nih.gov/pubmed/35547442
http://dx.doi.org/10.7759/cureus.23951
Descripción
Sumario:The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant challenges revolving around its development, affordability, accessibility, and acceptability at both a country level and an individual level. The main challenge faced by developed countries is the acceptability of the COVID-19 vaccine and the main challenge faced by developing countries is the affordability and accessibility of the COVID-19 vaccine.

Ejemplares similares